Cancer drug margins hit 700% as centre moves to curb excessive pricing

The Centre told the Supreme Court cancer-drug trade margins can reach 700%.
The government proposes capping margins on non-scheduled cancer medicines at 30% of MRP.
Officials expect the proposed cap to reduce cancer-drug prices by 20% to 70%.
The Centre estimates the measure could save patients ₹2,500 crore annually once implemented.

Get 100 stories a day on the app Read, watch & listen · Free on iOS & Android

Newer